Charles Schwab Investment Management Inc Royalty Pharma PLC Transaction History

Charles Schwab Investment Management Inc

$527 Billion
Q4 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Royalty Pharma PLC stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 3,131,628 shares of RPRX stock, worth $104 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,131,628

Previous 3,001,603 4.33%

Holding current value

$104 Million

Previous $84.9 Million 5.92%

% of portfolio

0.02%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	BUY	$24.28 - $28.39 $3.16 Million - $3.69 Million	130,025 Added 4.33%	3,131,628 $79.9 Million
Q3 2024 Nov 12, 2024	BUY	$25.63 - $29.27 $28.3 Million - $32.3 Million	1,103,341 Added 58.12%	3,001,603 $84.9 Million
Q2 2024 Aug 12, 2024	BUY	$26.26 - $29.9 $1.71 Million - $1.95 Million	65,257 Added 3.56%	1,898,262 $50.1 Million
Q1 2024 May 08, 2024	BUY	$27.46 - $31.33 $1.7 Million - $1.94 Million	62,017 Added 3.5%	1,833,005 $55.7 Million
Q4 2023 Feb 06, 2024	BUY	$26.21 - $29.22 $3.2 Million - $3.57 Million	122,084 Added 7.4%	1,770,988 $49.7 Million
Q3 2023 Nov 08, 2023	BUY	$26.26 - $31.38 $4.55 Million - $5.44 Million	173,315 Added 11.75%	1,648,904 $44.8 Million
Q2 2023 Aug 09, 2023	BUY	$29.6 - $36.56 $2.01 Million - $2.49 Million	68,052 Added 4.83%	1,475,589 $45.4 Million
Q1 2023 May 11, 2023	BUY	$32.77 - $39.4 $1.52 Million - $1.83 Million	46,358 Added 3.41%	1,407,537 $50.7 Million
Q4 2022 Feb 13, 2023	BUY	$39.17 - $44.04 $3.29 Million - $3.69 Million	83,896 Added 6.57%	1,361,179 $53.8 Million
Q3 2022 Nov 14, 2022	BUY	$39.88 - $44.65 $4.39 Million - $4.91 Million	109,998 Added 9.42%	1,277,283 $51.3 Million
Q2 2022 Aug 15, 2022	BUY	$37.53 - $44.22 $3.49 Million - $4.11 Million	92,864 Added 8.64%	1,167,285 $49.1 Million
Q1 2022 May 13, 2022	BUY	$37.46 - $42.44 $3.23 Million - $3.66 Million	86,335 Added 8.74%	1,074,421 $41.9 Million
Q4 2021 Feb 11, 2022	BUY	$35.17 - $42.48 $1.48 Million - $1.78 Million	41,987 Added 4.44%	988,086 $39.4 Million
Q3 2021 Nov 16, 2021	BUY	$36.14 - $42.24 $24.6 Million - $28.7 Million	680,274 Added 255.91%	946,099 $34.2 Million
Q2 2021 Aug 16, 2021	BUY	$39.85 - $46.63 $824,416 - $964,681	20,688 Added 8.44%	265,825 $10.9 Million
Q1 2021 May 17, 2021	BUY	$42.34 - $52.82 $2.74 Million - $3.41 Million	64,636 Added 35.81%	245,137 $10.7 Million
Q4 2020 Feb 16, 2021	SELL	$36.12 - $50.05 $1.24 Million - $1.72 Million	-34,354 Reduced 15.99%	180,501 $9.04 Million
Q3 2020 Nov 13, 2020	BUY	$38.56 - $48.36 $2.05 Million - $2.57 Million	53,188 Added 32.9%	214,855 $9.04 Million
Q2 2020 Aug 14, 2020	BUY	$44.5 - $52.11 $7.19 Million - $8.42 Million	161,667 New	161,667 $7.85 Million

Others Institutions Holding RPRX

# of Institutions

429

Shares Held

294M

Call Options Held

508K

Put Options Held

118K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $14.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Royalty Pharma PLC Transaction History